Many advancements in the setting up of the new pharmaceutical legislation

On 11 December 2025, the Trilogue reached an agreement on the final text of the “pharma package”, which includes the regulations and directives governing the development, production and commercialisation of medicinal products in the EU. The package now awaits formal adoption by the European Council and Parliament before it can enter into force. We summarise the main features of the reform of the European pharmaceutical legislation

Bacteriophages and AMR, the beginning of a new era?

The newly published EMA draft guideline on the quality aspects of phage therapy medicinal products paves the way for the use in Western Europe of this new - albeit century-old - approach to treating antibiotic-resistant infections